Performance of Screening Breast MRI across Women with Different Elevated Breast Cancer Risk Indications

Sippo, Dorothy A.; Burk, Kristine S.; Mercaldo, Sarah; Rutledge, Geoffrey M.; Edmonds, Christine E.; Guan, Zoe; Hughes, Kevin S.; Lehman, Constance

doi:10.1148/radiol.2019181136

Cited by 56 publications

(37 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although not covered in the time period of the current study, in 2018, the American College of Radiology (ACR) recommended the use of breast MRI among women diagnosed with breast cancer at aged <50 years or if they had dense breast tissue, 21 based on observational studies indicating a potential benefit. 22,23 However, studies also have shown that breast MRI does not have improved accuracy over mammography among women with a prior breast cancer diagnosis. 24 The 2018 ACR guideline did not specifically mention women with BRCA mutations and a prior breast cancer diagnosis, a special population of women with elevated rates of breast MRI who may benefit from additional screening and the subgroup with among the highest rates historically.…”

Section: Discussionmentioning

confidence: 99%

Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016

Wernli

Callaway

Henderson

et al. 2020

Cancer

View full text Add to dashboard Cite

BACKGROUND: Supplemental breast cancer screening with breast magnetic resonance imaging (MRI) is recommended for women at high risk of breast cancer. To the authors' knowledge, recent national trends in breast MRI use are unknown. METHODS: The authors used claims data from a large national insurer to calculate screening breast MRI rates from 2006 to 2016 in a US cohort of 10 million women aged 20 to 64 years. Use was stratified by subgroups of women with a BRCA mutation, family history of breast cancer, and prior breast cancer history and stratified by age. Joinpoint regression evaluated annual changes in trends. RESULTS: The total sample included 37,447 screening breast MRI examinations in 25,617 women. Overall screening breast MRI rates were low and increased from 2.9 to 12.1

show abstract

Section: Discussionmentioning

confidence: 99%

Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016

Wernli

Callaway

Henderson

et al. 2020

Cancer

View full text Add to dashboard Cite

show abstract

“…Additionally, the differences in prevalence of women with and without genetic risks due to either mutation carriers or family history dictate screening modality recommendations [34,35]. Sippo et al reported the prevalence of multiple risk factors among those with PHBC after excluding those with BRCA mutation or a history of chest radiation, and while the majority (88%) did not have other risk factors, 12% reported having a family history or high-risk lesion [27].…”

Section: Discussionmentioning

confidence: 99%

“…Abnormal interpretation rate-Recall rates ranged from 6 to 31% among 10,743 examinations. Brennan et al reported the highest percentage of examinations interpreted as positive, 31% (95% CI [23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39]. The remaining studies ranged from 6 to 19%.…”

Section: Test Characteristicsmentioning

confidence: 99%

Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis

Haas

Nekhlyudov

Lee

et al. 2020

Breast Cancer Res Treat

View full text Add to dashboard Cite

Purpose-Women with personal history of breast cancer (PHBC) are currently recommended to receive annual mammography for surveillance of breast cancer recurrence or new primary. However, given issues in accuracy with mammography, there is a need for evolving evidencebased surveillance recommendations with supplemental imaging. In this systematic review, we compiled and compared existing studies that describe the test performance of surveillance breast MRI among women with PHBC. Methods-We searched PubMed and EMBASE using MeSH terms for studies (2000-2019) that described the diagnostic characteristics of breast MRI in women with PHBC. Search results were reviewed and included based on PICOTS criteria; quality of included articles was assessed using QUADAS-2. Meta-analysis of single proportions was conducted for diagnostic characteristics of breast MRI, including tests of heterogeneity.

show abstract

“…The EVA trial looked at 687 asymptomatic women at elevated familial risk and found that MRI screening shifts the distribution of screen-detected breast cancers toward the preinvasive stage. 33 35 This finding suggests that given the low CDR, women with increased familial risk may benefit from other risk-assessment strategies beyond MRI.…”

Section: Screeningmentioning

confidence: 97%

Management of women at increased risk for breast cancer secondary to high‐risk proliferative lesions and family history of the disease

2020

View full text Add to dashboard Cite

Women with breast biopsies showing high‐risk proliferative lesions such as atypical hyperplasia (AH) and lobular carcinoma in situ (LCIS) have an increased risk of developing breast cancer. Other factors including age, family history of breast cancer, and extent of AH may play a role in increasing breast cancer risk. In addition to women with AH, there is a subset of women with a positive family history of breast cancer, without a known germline mutation, which places them also at an increased risk for breast cancer. Clinical management, screening, chemoprevention, and surgical risk‐reduction are discussed in this review to inform the management of these high‐risk women. Advanced imaging technology, pharmacologic research into different targets, and innovations in breast reconstruction are changing the way in which patients are counseled of their individual risk.

show abstract

Performance of Screening Breast MRI across Women with Different Elevated Breast Cancer Risk Indications

Cited by 56 publications

References 23 publications

Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016

Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016

Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis

Management of women at increased risk for breast cancer secondary to high‐risk proliferative lesions and family history of the disease

Contact Info

Product

Resources

About